| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/29/2006 | EP1482934B1 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases |
| 03/29/2006 | EP1467998B1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 03/29/2006 | EP1395563B1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 03/29/2006 | EP1385496A4 Use of compositions for treating rosacea |
| 03/29/2006 | EP1358354B1 Method for identifying compounds modulating reverse cholesterol transport |
| 03/29/2006 | EP1289552B1 Methods for treating hemostatic disorders by soluble p-selectin |
| 03/29/2006 | EP1077715B1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 03/29/2006 | EP0990031B1 Tumor necrosis factor receptor 5 |
| 03/29/2006 | EP0956023B1 Use of progesterone for treating or reducing ischemia in menopausal women receiving estrogen |
| 03/29/2006 | EP0914427B1 Plasmid-based vaccine for treating atherosclerosis |
| 03/29/2006 | EP0852495B1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 03/29/2006 | CN1753886A Process for producing acid adduct salt of polyacidic base compound |
| 03/29/2006 | CN1753885A Optically active dihydropyridine derivative |
| 03/29/2006 | CN1753881A 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis. |
| 03/29/2006 | CN1753879A (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexylmethoxy acetic acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis. |
| 03/29/2006 | CN1753877A Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 03/29/2006 | CN1753693A Uses of anti-insulin-like growth factor I receptor antibodies |
| 03/29/2006 | CN1753669A Hypertonia treatment during the acute phase of a cerebrovascular accident |
| 03/29/2006 | CN1753667A Composition having autonomic nerve modulating activity and method of use thereof |
| 03/29/2006 | CN1751741A Nano carbon tube infusion agent, its prepn. method and application in treating cancer, cardiovascular disease and infectious disease |
| 03/29/2006 | CN1751710A Novel administration route of injection-free type used in summer, prepn. process and indication thereof |
| 03/29/2006 | CN1751706A Method for extraction of red-rooted salvia |
| 03/29/2006 | CN1751705A Traditional Chinese medicine prepn. contg. red-rooted salvia |
| 03/29/2006 | CN1751704A Traditional Chinese medicine injection contg. red-rooted salvia |
| 03/29/2006 | CN1751699A Sofflower injection and its prepn. method |
| 03/29/2006 | CN1751694A Polyporus frondosus oral liquor and its prodn. method |
| 03/29/2006 | CN1751693A Application of astragaloside in medicine for treating or preventing insulin resistance |
| 03/29/2006 | CN1751692A Medicine Rb2 used for thrombolysis, anti reperfusion injury, improving microcirculation and repairing injured tissue and its prepn. method |
| 03/29/2006 | CN1751689A Method for preparing medicine composition contg. aspirin |
| 03/29/2006 | CN1751687A Medicine composition and its application in prepn. of medicine for treating or preventing cardiovascular and cerebrovascular diseases |
| 03/29/2006 | CN1751598A Diet-therapy product prodn. method |
| 03/29/2006 | CN1247784C Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 03/29/2006 | CN1247782C Actinia neurotoxin gene and its application |
| 03/29/2006 | CN1247781C Actinia neurotoxin gene and its application |
| 03/29/2006 | CN1247613C Novel omega-conotoxin peptides |
| 03/29/2006 | CN1247593C Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 03/29/2006 | CN1247589C Tricyclic derivatives of indole with antiangiogenic activity |
| 03/29/2006 | CN1247586C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 03/29/2006 | CN1247585C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives |
| 03/29/2006 | CN1247583C Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound |
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247573C Method for preparing arylacetyl aminothiazole |
| 03/29/2006 | CN1247568C Novel urea compounds as vanilloid receptor antagonist for treatment of pains |
| 03/29/2006 | CN1247567C 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors |
| 03/29/2006 | CN1247564C Enrichment of ligusticum lactone and its preparations |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/29/2006 | CN1247544C Anthranilic acid amides with heteroarylsulfonyl side chain and use thereof as active substance for antiarythmia |
| 03/29/2006 | CN1247542C Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 03/29/2006 | CN1247538C Alkyl sulfonamide phenyl alkylamide compound and its prepn and medicinal use |
| 03/29/2006 | CN1247528C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 03/29/2006 | CN1247523C Substituted 1 and 2 naphthol mannich bases |
| 03/29/2006 | CN1247491C Extraction process for total phenolic acid of salvia root and pharmacutical application thereof |
| 03/29/2006 | CN1247256C Pharmaceutical combination for treatment of tissue damage owing to arterial irrigation defect |
| 03/29/2006 | CN1247254C Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 03/29/2006 | CN1247247C Apoplexy treating Chinese traditional medicine and its preparation |
| 03/29/2006 | CN1247241C Liuwei Dihuang dripping pills |
| 03/29/2006 | CN1247240C Herbal medicine compositions for treatment allergic rhinitis and use thereof |
| 03/29/2006 | CN1247237C Medicinal composition for treating coronary disease and its preparation process |
| 03/29/2006 | CN1247233C Chinese medicine for varicose vein |
| 03/29/2006 | CN1247228C Method for preparing Qi-benefiting and blood circulation-promoting pill for treating insufficienty of heart-qi coronary heart disease |
| 03/29/2006 | CN1247219C Medicine for treating piles |
| 03/29/2006 | CN1247213C Medicinal composition for treating apoplexia, and preparing method and use thereof |
| 03/29/2006 | CN1247205C Sea cucumber carotenoid lipid fraction products and method of use |
| 03/29/2006 | CN1247202C Dioscin oral disintegration tablet and its preparing method |
| 03/29/2006 | CN1247187C Intravenous injection liquid preparing method of oxygen-enriched broad transfusion |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019123 Human bikunin |
| 03/28/2006 | US7019108 Especially the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini. |
| 03/28/2006 | US7019013 Sulfamidothienopyrimidines |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7019004 Agonists of imidazolidine-2,4-dione derivatives, chemical intermediates, for treating anxiety, depression, schizophrenia, neurodegenerative diseases, dementia, epilepsy, endocrinological disorders associated with excess of hormone, tumor |
| 03/28/2006 | US7019001 Substituted benzothiazole amide derivatives |
| 03/28/2006 | US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease |
| 03/28/2006 | US7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors |
| 03/28/2006 | US7018985 Composition and method for inhibiting platelet aggregation |
| 03/28/2006 | US7018797 Method for treating neurodegenerative disorders |
| 03/28/2006 | US7018662 Palliative effects of morinda citrifolia oil and juice |
| 03/28/2006 | US7018659 256 Daltons compound, non proteinesious in nature,with an Ultraviolet spectra in methanol as a solvent produces a sharp peak at 225.4 nm |
| 03/28/2006 | US7018658 Pharmaceutical pellets comprising tamsulosin |
| 03/28/2006 | US7018395 to destroy or impair target cells expressing a vascular endothelial growth factor (VEGF) receptor by administering a liposome system of conjugated antibodies, conjugated photosensitizer and another liposome conjugate and using light of an intensity such that nontarget cells are not destroyed |
| 03/28/2006 | US7017573 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 03/28/2006 | CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/28/2006 | CA2309551C Aminothiazole inhibitors of cyclin dependent kinases |
| 03/28/2006 | CA2156121C Method of manufacturing the cycloheptimidazole derivatives |
| 03/28/2006 | CA2147451C 3-indolylpiperidines |
| 03/28/2006 | CA2125104C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/23/2006 | WO2006031922A2 Thyroid hormone analogs for promoting angiogenesis |
| 03/23/2006 | WO2006031786A2 Protein a compositions and methods of use |
| 03/23/2006 | WO2006031505A1 Purine derivatives as a3 and a1 adenosine receptor agonists |
| 03/23/2006 | WO2006031467A2 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
| 03/23/2006 | WO2006030947A1 Joint use of sulfonamide based compound with angiogenesis inhibitor |
| 03/23/2006 | WO2006030941A1 Simultaneous use of sulfonamide-containing compound and angiogenesis inhibitor |
| 03/23/2006 | WO2006030898A1 Aldose reductase inhibitor |
| 03/23/2006 | WO2006030826A1 Medicinal composition |
| 03/23/2006 | WO2006030805A1 Triazole derivative or salt thereof |
| 03/23/2006 | WO2006030771A1 Gnetum extract |
| 03/23/2006 | WO2006030306A2 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
| 03/23/2006 | WO2005046658A3 Methods of modulating angiogenesis and cancer cell proliferation |
| 03/23/2006 | US20060063942 Mitotic kinesin inhibitors |
| 03/23/2006 | US20060063941 Perindopril |